EcoDrugPlus

Renin

Ensembl ID : ENSPREG00000016088
Gene Symbol: REN
3 Cross references
219 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSPREG00000002410
Gene Symbol: RET
3 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Rxr-Beta-A-Like

Ensembl ID : ENSPREG00000002487
Gene Symbol: LOC103478548
3 Cross references
211 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSPREG00000013651
Gene Symbol: RARB
4 Cross references
392 Possible Orthologues:

Retinoic Acid Receptor Beta-Like

Ensembl ID : ENSPREG00000001598
Gene Symbol: LOC103477705
2 Cross references
380 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSPREG00000020428
Gene Symbol: RARG
4 Cross references
325 Possible Orthologues:

Retinoic Acid Receptor Gamma-A-Like

Ensembl ID : ENSPREG00000014967
Gene Symbol: LOC103465339
3 Cross references
373 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSPREG00000006075
Gene Symbol: RPL10
3 Cross references
407 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSPREG00000022666
Gene Symbol: RPL10A
3 Cross references
366 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSPREG00000008204
Gene Symbol: RPL11
3 Cross references
288 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSPREG00000023190
Gene Symbol: RPL13
3 Cross references
275 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSPREG00000020079
Gene Symbol: RPL13A
3 Cross references
368 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).